Health Care Equipment & Services

Sonova’s latest market outlook shows modest share‑price decline but strong fundamentals, highlighting its wireless hearing‑aid innovation, evolving reimbursement strategy, and supply‑chain resilience.

Siemens Healthineers pivots to a fully AI‑driven medical‑tech entity, divesting industrial ties and boosting share buy‑backs, reshaping its market role and investor outlook.

Explore Cencora Inc.’s dividend hike, market performance vs. the S&P 500, and how QIVIGY®’s nationwide launch reflects broader pharma growth.

Labcorp’s new board ties to AI‑driven diagnostics & data‑analytics, offering a strategic boost in revenue, compliance, and cross‑industry growth.

Demant A/S’s March 2026 AGM shows steady hearing‑care strategy, resilient margins, and tech‑driven growth amid Nordic market pullbacks.

Sonova Holding AG’s shares stay steady amid a weak Swiss market, proving resilience in the hearing‑tech sector and reassuring investors about its innovation focus.

Steris plc receives a strong‑buy upgrade amid solid earnings, high demand for infection‑control tech, and a favorable market position.

Insulet’s steady revenue growth, margin gains and heavy R&D investment show promise, but regulators, reimbursement shifts and fierce competition risk delaying its next‑generation closed‑loop breakthrough.

Coloplast names Gavin Wood as CEO, a move that could steer the Danish medical‑device firm toward digital health, faster approvals, and higher growth while balancing cost efficiency.

Veeva’s Q4 earnings beat forecasts, powered by AI‑enhanced CRM and high‑margin life‑science cloud services, but analysts weigh valuation premiums against AI risks and market tightening.